Background/Aims: This retrospective study analysed hypertension management and adherence to blood pressure (BP) targets among renal transplant recipients (RTRs) under specialized care in the Outpatient Transplantation Unit in the Department of Nephrology, Transplantology and Internal Medicine at Gdansk University Hospital. Methods: Medical records of 101, 316, 639 and 818 RTRs diagnosed with hypertension, who received outpatient care in 2001, 2006, 2011 and 2014, respectively were analysed in four independent cross-sectional surveys. All RTRs received antihypertensive regimens. Results: The overall most commonly used antihypertensive agents were beta-blockers (BB) (range 66.3-82.5%) followed by calcium channel blockers (CCB) (range 52.8-64.2%). Whilst a significant, upward tendency of BB usage (p<0.01) was observed, CCB usage (p<0.001) displayed a downward tendency as a first line therapy in the subsequent years. The average number of antihypertensive agents used per patient increased significantly from 2.24±1.03 in 2001 to 2.55±1.25 in 2014 (p<0.05). The most frequently used combination of hypotensive therapy consisted of two or three antihypertensive drugs depending on the survey. The most common two drug combination consisted of BB and CCB followed by BB accompanied by angiotensin converting enzyme inhibitors. A significant, upward tendency in the use of four (p<0.001) and five (p<0.05) antihypertensive drugs simultaneously, was observed in subsequent years. The target values of BP i.e. <140/90 mmHg were accomplished in 47, 58, 60 and 46% of RTRs in subsequent years. In a secondary - stratified analysis of data from 2014, younger patients (p<0.05), patients with better graft function (p<0.001), patients treated with a higher number of antihypertensive agents (p<0.001) and those not treated with BB (p<0.01) were shown to reach the BP target of below 140/90 mmHg more often. Conclusion: The study showed intensification of hypertension treatment in RTRs in subsequent years with BB assuming a dominant role.

Background: Ultrasonography protocols are easy to learn, frequently used in emergency medicine, and could be useful for inexperienced doctors. Inthis field, only a few protocols are needed to give an initial diagnosis and to start fast and proper treatment. Until now, only Focused Assessmentwith Sonography for Trauma (FAST) protocol training studies have been reported in the medical literature. Our point-of-care course, comprisedof extended FAST, lung scan and ocular scan trainings. The students’ curriculum usually does not include such ultrasonography courses, thus,we wanted to check its utility for the undergraduate medical students. Methods: Training lasted six days and consisted of two parts: 22 hoursof theoretical classes and 18 hours of practical activities, all trained and evaluated by six experienced medical doctors. Eighty-five electedstudents completed pre- and post-study questionnaires about emergency ultrasonography and passed the practical final exam. Results: Eighty-fiveparticipants of the course were present in the pre- and final test. Final test scores of theoretical and practical exams were significantly higherafter the training (58% vs. 87%; n=85; p<0.01). Answers for the questions related to FAST and EFAST (extended FAST) were correct irrespectiveof completion of the course. A question regarding the sonographic evaluation of body fluid incontinence was found to be the most difficult forstudents. After the course, 96.5% of participants were able to complete an EFAST scan at an adequate level of performance in under two minutes.Conclusion: Results show that medical students significantly extended their knowledge about point-of-care emergency medicine ultrasonographyand acquired practical skills during the course. Emergency medicine ultrasonography courses could be included into medical students’ curricula.

Background/Objective: Postoperative pain and delirium are frequent and clinically relevant complications in patients undergoing major cardiac or neurosurgical procedures. The interaction between these conditions remains insufficiently characterized, particularly across heterogeneous surgical populations. This study aimed to investigate the relationship between postoperative pain intensity and delirium severity within the first 48 h after surgery in cardiac and neurosurgical patients. Methods: This retrospective observational analysis included 408 individuals—202 following cardiac surgery and 206 after neurosurgical procedures. Pain intensity was measured using the Numerical Rating Scale (NRS), while delirium presence and severity were assessed using the CAM-ICU and CAM-ICU-7 instruments. Associations between NRS scores, delirium severity, demographic characteristics, and ICU length of stay were examined. Results: Cardiac surgery patients experienced higher pain levels on postoperative day 1 compared with neurosurgical patients; this difference was not observed on day 2. In the cardiac cohort, higher NRS scores were positively associated with greater delirium severity on both postoperative days. No such association was detected in the neurosurgical group. Pain scores also differed across procedure types within each specialty, and several demographic variables (age, sex, ICU stay duration) were linked with variations in pain intensity. On postoperative day 1, pain intensity showed a moderate association with delirium severity (Spearman ρ = 0.23; 95% CI 0.14–0.32). Patients who developed delirium had higher pain scores (r = 0.25). In ordinal logistic regression, greater pain on postoperative day 1 independently predicted higher delirium severity (OR 2.24; 95% CI 1.70–2.94). Conclusions: Significant associations between postoperative pain intensity and delirium severity were identified in cardiac surgery patients, whereas no similar pattern emerged among neurosurgical patients. Given the retrospective design and incomplete data on perioperative pharmacotherapy, the findings should be interpreted descriptively and do not support causal conclusions. These results underscore the importance of systematic monitoring of pain and cognitive function in high-risk postoperative populations and highlight the need for prospective studies to elucidate the complex interplay between pain, perioperative factors, and postoperative delirium.

Background/Objectives: The increasing number and complexity of cardiac and neurosurgical procedures underscore the importance of effective perioperative care. One of the most serious postoperative complications is delirium, which prolongs hospitalization, increases treatment costs, worsens rehabilitation outcomes, and increases mortality. Identifying biomarkers that predict delirium can improve patient outcomes. The aim of this study was to assess the relationship between C-reactive protein (CRP) levels and the incidence of postoperative delirium in patients after cardiac and neurosurgical procedures hospitalized in the intensive care unit. Methods: A retrospective study was conducted on 408 patients (202 undergoing cardiac surgery and 206 undergoing neurosurgery) who underwent surgery between April 2024 to the end of August 2024. Medical records were reviewed for the occurrence of delirium assessed using the Confusion Assessment Method-Intensive Care Unit scale (CAM-ICU), its severity assessed using the Confusion Assessment Method–Intensive Care Unit 7 (CAM-ICU-7), and laboratory test results, with particular emphasis on C-reactive protein levels. CRP levels were measured on postoperative days 1 and 2. Results: Postoperative delirium was noted in both groups, more frequently in patients with elevated CRP levels, indicating an active inflammatory process. In the neurosurgical group, episodes of severe delirium occurred primarily after laminectomy, whereas in the cardiac surgery group, they were most common after coronary artery bypass grafting (CABG). Conclusions: Elevated CRP levels are associated with a higher risk of postoperative delirium. Monitoring inflammatory parameters and implementing early preventive measures may improve treatment outcomes and shorten hospital stays. Further prospective studies using standardized diagnostic tools are necessary.

Background/Objectives: Spinal cord stimulation (SCS) is an established therapy for chronic refractory pain, but its clinical value depends on whether benefit persists beyond the early post-implant period. Although short-term SCS studies are abundant, reports with follow-up of 24 months or longer are dispersed, methodologically heterogeneous, and difficult to interpret across indications and stimulation platforms. This scoping review aimed to map the clinical literature reporting SCS outcomes at ≥24 months, characterize the represented populations and modalities, summarize the long-term outcome domains assessed, and identify major methodological and clinical gaps in the evidence base. Methods: This PRISMA-ScR-informed scoping review applied a Population–Concept–Context framework. PubMed/MEDLINE and Scopus were searched through April 2026, yielding 6866 records before deduplication. Following staged title/abstract screening, iterative full-text retrieval, and the reconciliation of overlapping publications, 292 unique full-text reports were assessed for eligibility. Studies reporting original clinical SCS data with extractable outcomes at ≥24 months were included. No meta-analysis or formal GRADE assessment was undertaken, as the objective was evidence mapping rather than pooled effect estimation. Results: The final evidence map comprised 65 unique reports representing a cumulative report-level population of 11,518 participants across non-overlapping cohorts. The literature was dominated by non-randomized evidence (55 observational reports; 10 randomized or randomized-derived). The most frequent indication was mixed chronic pain (30/65; 46.2%), followed by failed back surgery syndrome/persistent spinal pain syndrome (FBSS/PSPS; 16/65; 24.6%), chronic back and/or leg pain (6/65; 9.2%), complex regional pain syndrome (CRPS; 5/65; 7.7%), and painful diabetic neuropathy (PDN; 4/65; 6.2%). Most reports involved conventional or unspecified SCS (47/65; 72.3%), with smaller contemporary clusters for 10 kHz high-frequency SCS and ECAP-controlled closed-loop SCS. The most frequently reported outcome domains were pain durability, function and quality of life, device-related outcomes, and opioid use. At a descriptive level, the literature more often supported persistence of benefit than complete erosion of effect, particularly in spinal pain populations and in contemporary PDN and closed-loop SCS cohorts. Interpretation was constrained by outcome heterogeneity, cohort overlap, mixed indication categories, and inconsistent opioid and device-maintenance reporting. Conclusions: The long-term SCS literature supports the view that durable benefit is achievable in a substantial patient subset, particularly in FBSS/PSPS populations, and in more recent evidence, in PDN, nonsurgical refractory back pain, and closed-loop SCS cohorts. The evidence base remains heterogeneous and does not support a uniform certainty-ranked estimate across indications and technologies. Future studies should prioritize indication-specific cohorts, standardized multidomain outcome reporting, and transparent separation of unique cohorts from secondary analyses of the same clinical populations.